cimetidine has been researched along with Hypertrophic Pyloric Stenosis in 2 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banieghbal, B | 1 |
| Denavit, MF | 1 |
| Guerin, J | 1 |
| Caldera, R | 1 |
| Rossier, A | 1 |
2 other studies available for cimetidine and Hypertrophic Pyloric Stenosis
| Article | Year |
|---|---|
Rapid correction of metabolic alkalosis in hypertrophic pyloric stenosis with intravenous cimetidine: preliminary results.
Topics: Alkalosis; Cimetidine; Female; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Infusions, | 2009 |
[Duodenal ulcer in a newborn].
Topics: Anti-Ulcer Agents; Blood Transfusion; Cesarean Section; Cimetidine; Combined Modality Therapy; Cryot | 1978 |